Navigation Links
Fertility Clinic Web Sites Doesn’t Adhere to Ad-Guideline

A University of Illinois at Chicago study published in the January issue of Fertility and Sterility shows that the majority of fertility clinic Web sites does not adhere// to their own association's advertising guidelines.

The study also found that services offered at private clinics and academic clinics were similar, but private clinics were more likely to publish success rates, use comparative marketing, and offer financial incentives.

Many consumers rely on the Internet to gather health information, and "the concern is that vulnerable patients may be misled by information that does not give the whole picture," said Dr. Tarun Jain, assistant professor of reproductive endocrinology and infertility at the UIC College of Medicine and senior author of the study.

Advertising guidelines adopted by the Society for Assisted Reproductive Technology (SART) and the American Society for Reproductive Medicine (ASRM) seek to improve the accuracy of online information for patients. The guidelines, which are mandatory for membership in SART, require clinics to provide specific information about how in vitro fertilization outcome statistics are reported, mandate that clinics follow Federal Trade Commission guidelines, and warn against the comparison of success rates between clinics.

In the new study, researchers evaluated 289 SART-registered clinics (211 private and 78 academic) with functional Web sites.

They assessed several Web site characteristics including the publication of success rates, additional data to support success rates, comparison marketing, and the presence of a disclaimer stating that "a comparison of success rates may not be meaningful because patient medical characteristics and treatment approaches may vary from clinic to clinic."

The researchers found that approximately half of the Web sites published success rates, and of those, the percentage adhering to the advertising guidelines was low in all c ategories evaluated.

"Despite an attempt to clarify assisted reproduction information on the Internet, there is a great deal of disparity among how clinics publish success rates on their Web sites," said Jain. "Patients need to carefully evaluate the information presented on Web sites, and they need to know what questions to ask when they meet face-to-face with a physician."

Thirty-six percent of private clinics and 22 percent of academic clinics complied with the advertising guidelines by providing specific information about the method used to calculate success rates. Only 44 percent of clinic Web sites that published success rates included the mandatory disclaimer statement.

The researchers also evaluated Web sites for advertising specific services, including donor egg program, embryo and egg cyropreservation, pre-implantation genetic diagnosis, sex selection, shared-risk financing and 100 percent money-back guarantees.

Private clinic Web sites were significantly more likely than academic clinics to offer financial incentives, including shared risk financing, and to use the catchphrase "100 percent Money Back Guarantee."

According to Jain, the ASRM/SART advertising guidelines have not been strictly enforced. However, in some cases, the FTC has audited and penalized fertility practices for misrepresenting the success rates of their in vitro fertilization services.

Jain recommends that infertility patients not rely solely on success rates published on fertility clinic Web sites.

"Patients should meet with a prospective physician and have their questions answered in person," he said. "Success rates will vary depending on the patient's diagnosis, age and other factors, but unfortunately, many patients choose a practice based on information obtained on the Internet."

Source-Eurekalert
SRI
'"/>




Related medicine news :

1. Fertility After Testicular Cancer Questioned
2. Restoration Of Fertility After Cancer Treatment
3. Mobile Phones Found To Reduce A Man’s Fertility by 30
4. High-Protein Diet Found To Reduce Fertility
5. Suppressing A Girls Height In Adolescence Could Lead to Fertility Problems
6. Improving Fertility In Patients With Cervical Cancer
7. Late Pregnancy Women Face The Risk Of Heartbreak, Fertility Problems
8. Fertility Treatment Offered During Summer Has Better Chances For Success
9. Detrimental Effect Of Chronic Alcoholism On Male Fertility
10. Fertility increased in Thirties
11. New Home-Fertility Kit Launched For Men
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... , ... April 24, 2017 , ... ... they are seeking public support to bring their novel lifesaving device for the ... device packed with medical-grade sensors, specially designed to read a child’s vital signs, ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... expected to be diagnosed globally; approximately 25,000 of them will be malignant.(1) As ... use of this type of healthcare model in the diagnosis and treatment of ...
(Date:4/24/2017)... Montclair, NJ (PRWEB) , ... April 24, 2017 , ... ... International Plaza Hotel, 4200 Jim Walter Blvd, for an educational and exciting 2-day program. ... all of our staff hearing this before they approach patients” about the course entitled ...
(Date:4/24/2017)... ... ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues”: a guide to ... Navigate Life Issues” is the creation of published author, Rachel Jamerson, writer of 25 ... CONTACT USA, and former member of the American Association of Christian Counselors. Rachel ...
(Date:4/24/2017)... ... April 24, 2017 , ... Anaconda BioMed, a pre-clinical ... for the treatment of Acute Ischemic Stroke (AIS), today announced it has appointed ... product advances towards regulatory and clinical phases. , "This is another important step ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ABBV), ... percent (n=145/146) of chronic hepatitis C virus (HCV) ... or 6 and compensated cirrhosis (Child-Pugh A) achieved ... 12 ) with its investigational, pan-genotypic regimen of ... were seen following 12 weeks of G/P treatment ...
Breaking Medicine Technology: